Table 3 The comparison of 5-year outcomes between the diabetic group and nondiabetic group
Clinical endpoint | Overall (n = 1205) | Crude HR (95% CI) | Adjusted HR (95% CI) | |
|---|---|---|---|---|
No diabetes (n = 834) | Diabetes (n = 371) | |||
MACCE | 281 (33.7) | 128 (34.5) | 1.075 (0.872–1.325) | 1.012 (0.815–1.255) |
Cardiac death/MI/stroke | 111 (13.3) | 46 (12.4) | 0.976 (0.692–1.377) | 0.869 (0.608–1.242) |
All-cause death | 80 (9.6) | 32 (8.6) | 0.935 (0.620–1.409) | 0.785 (0.512–1.203) |
Cardiac death | 37 (4.4) | 19 (5.1) | 1.210 (0.696–2.104) | 0.982 (0.549–1.757) |
MI | 58 (7.0) | 22 (5.9) | 0.884 (0.541–1.444) | 0.855 (0.515–1.419) |
Stroke | 20 (2.4) | 11 (3.0) | 1.280 (0.613–2.671) | 1.148 (0.540–2.440) |
Unplanned revascularization | 187 (22.4) | 88 (23.7) | 1.084 (0.841–1.396) | 1.065 (0.826–1.374) |